Skip to main content

Acute Bacterial Skin and Skin Structure Infections

4
Pipeline Programs
5
Companies
2
Clinical Trials
1
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
3
1
Early DiscoveryClinical DevelopmentMarket

On Market (1)

Approved therapies currently available

Merck & Co.
SIVEXTROApproved
tedizolid phosphate
Merck & Co.
intravenous2014

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
1
Tedizolid phosphatePHASE_3
Wockhardt
WockhardtNJ - Parsippany
1 program
1
Oral Levonadifloxacin/Linezolid TabletPhase 31 trial
Active Trials
NCT03405064Completed501Est. Nov 2018
MSD
MSDIreland - Ballydine
1 program
1
Tedizolid phosphatePhase 31 trial
Active Trials
NCT03176134Completed100Est. Jul 2023
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
1 program
1
Tedizolid phosphatePhase 3

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MSDTedizolid phosphate
WockhardtOral Levonadifloxacin/Linezolid Tablet

Clinical Trials (2)

Total enrollment: 601 patients across 2 trials

NCT03176134MSDTedizolid phosphate

A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)

Start: Jan 2019Est. completion: Jul 2023100 patients
Phase 3Completed
NCT03405064WockhardtOral Levonadifloxacin/Linezolid Tablet

Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Start: Aug 2017Est. completion: Nov 2018501 patients
Phase 3Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 late-stage (Phase 3) programs, potential near-term approvals
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.